InsidersTradesSigma
Follow the Genscript Biotech Corporation share price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares trade on the HK market, under the oversight of HKEX. Operating in the Health Care sector, Genscript Biotech Corporation has published 17 reports. Market capitalisation: €79.6bn. The latest transaction was reported on 7 September 2026 (Sale). Among the most active insiders: Zhu Li. Every trade is openly available.
17
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
€2m
8 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Genscript Biotech Corporation Strong Buy (bullish), based on 7 analysts. Average price target: HK$29.16.
25Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,291 of 29,063 companies
33.2
score / 100
Value35
Quality31
FCF yld0.3%
Earn yld-0.7%
EV/EBITDA·
ROE-15%
Gross mgn58%
Net mgn-56%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 September 2026
Declarations17 total
155,535 shares@ HK$35.7448ShareXHKGHKEX:DA20260904E00490
3,907,209 sharesShareXHKGHKEX:DA20260625E00322
7,693,304 sharesShareXHKGHKEX:DA20260625E00320
5,270,879 sharesShareXHKGHKEX:DA20260625E00318
313,650 shares@ HK$12.12060.0062% mcap95.1% of flowShareXHKGHKEX:DA20260609E00352
169,561 sharesShareXHKGHKEX:DA20260609E00356
113,041 sharesShareXHKGHKEX:DA20260609E00361
841,470 sharesShareXHKGHKEX:DA20260609E00353
16,071 shares@ HK$12.25080.0003% mcap100.0% of flowShareXHKGHKEX:DA20260410E00415
17 of 17 declarations
关于 Genscript Biotech Corporation
Genscript Biotech Corporation 是一家生物技术公司，为药物开发提供研究服务和产品。该公司在香港证券交易所上市。